Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LEO 90100 twice-weekly maintenance regimen for psoriasis vulgaris
2016-000556-95Phase 3Completed
- Sponsor
- LEO Pharma
- Start
- Oct 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in plaque psoriasis comparing Enstilar twice-weekly maintenance with Vehicle twice-weekly maintenance (2 arms). Primary endpoint: Time to first relapse. Started Oct 2016; status: completed.
02
Drugs
calcipotriol
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on 2016-000556-95.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000556-95.